Abstract
Invasive prenatal testing, amniocentesis, and chorionic villus sampling offer insights into fetal genetic integrity and health, but carry inevitable minor risks of miscarriage and infection, thus complicating the decision-making process for parents. Previous research has revealed several factors that influence the decision to undergo invasive prenatal testing, including demographic, clinical, and psychological aspects, and attitudes towards testing. Informed choice, involving understanding options and aligning them with personal values, is crucial, with healthcare providers playing a key role in offering unbiased information. This systematic review aims to gather and synthesize literature data on the above factors to draw conclusions to aid antenatal care providers in supporting couples to make more informed decisions about their prenatal care.
A systematic search was performed in PubMed and PsycInfo databases using the appropriate keywords and an in-depth evaluation of the studies retrieved followed. Finally, 17 articles were eligible for our review investigating the decision-making process of invasive prenatal testing.
Factors like maternal age, education, and ethnicity are pivotal during the decision-making process. Clinical characteristics also influence decisions and women with pregnancies categorized as high-risk or those who have undergone fertility treatment display a preference for invasive testing. There seems to be a direct correlation between a woman's willingness to consider pregnancy termination, deeply rooted in psychological and moral stances, and the inclination to undergo invasive testing. In the patient decision-making process, the provision and depth of knowledge are of paramount importance. A comprehensive understanding facilitates more informed decisions. Finally, attitudes towards termination of pregnancy, as another factor influencing the decision-making process, reveal a nuanced landscape where personal beliefs, religious considerations, legal restrictions, and perspectives on disability converge. Within this complex context, religion emerges as an important determinant, shaping individuals' views on the morality of abortion.
This review sheds light on the most important factors influencing the couples’ consent for invasive prenatal testing. Healthcare professionals must identify which factors are critical in every specific case among several sociodemographic, clinical, emotional, and religious factors. Thus, they will be able to provide balanced and comprehensive information to help couples under this stressful procedure. We advocate for a patient-centered multidisciplinary approach while navigating couples through the intricate landscape of decision-making concerning invasive prenatal testing.
Keywords: healthcare guidance, informed choice, psychological influences, clinical characteristics, demographic factors, decision-making, invasive prenatal testing
Introduction and background
In recent decades, prenatal testing has become a common practice in most developed countries, offering to pregnant women and their partners valuable insights into the health of their fetus which also reflects its long-term prognosis. Invasive prenatal testing, encompassing procedures like amniocentesis and chorionic villus sampling (CVS), facilitates the collection of fetal cells or placental for subsequent genetic analysis, usually karyotyping and chromosomal microarray analysis (CMA) [1,2]. However, these invasive tests are associated with potential adverse events, including miscarriage and infection [3], thus rendering the consultation process challenging and the decision-making process complex and potentially stressful for prospective parents.
Extensive research has revealed several factors that influence the decision to undergo invasive prenatal testing, including demographic and clinical characteristics, psychological traits, and the knowledge, attitudes, and personal beliefs of the couple towards prenatal testing [4]. For instance, advanced maternal age, educational attainment, and income have been identified as factors influencing the decision-making process for invasive prenatal testing [4]. Clinical factors, such as the presence of particular risk of chromosomal abnormality during prenatal screening also play a pivotal role in the decision-making process. An increased risk of chromosomal abnormalities is frequently associated with advanced maternal age or abnormal ultrasound findings and may instigate parents towards invasive prenatal testing [5]. Furthermore, parental anxiety levels and perceived control over the decision-making process also contribute to the decision [6]. Finally, knowledge and attitudes regarding invasive prenatal testing, including beliefs about its benefits and risks, significantly impact decision-making [7].
As generally in medicine, during the above procedure, it is crucial to consider the concept of informed choice. Informed choice refers to the process of gathering relevant information about the available options, weighing the potential benefits and risks, and making a decision that aligns with the individual's values and preferences [8]. Information is offered through the respective healthcare specialist or a team of experts in the field. For prenatal testing usually this is done by fetal medicine consultant and/or a clinical geneticist. Studies have demonstrated that when individuals have access to comprehensive and accurate information about invasive prenatal testing, they are better equipped to make informed choices [9].
Healthcare providers play a critical role in facilitating informed choice by ensuring that individuals receive unbiased information about the procedures involved, potential risks and benefits, as well as the limitations of the tests [10]. This includes providing clear explanations and addressing any questions or concerns that individuals may have [11]. Recognizing and respecting individual values and beliefs is also crucial in promoting informed decision-making [12].
Given the complexity involved in making decisions on invasive prenatal testing, our aim was to systematically review the existing literature and consolidate the current evidence on the factors influencing this decision. Through a comprehensive analysis of the available data, this study aims to identify and analyze the diverse demographic, clinical, psychological, and knowledge-related factors that affect the decision making to undergo invasive prenatal testing. By gaining a deeper understanding of the factors contributing to this decision, healthcare providers can adjust their practice and offer enhanced support to pregnant women and their partners, enabling them to make the appropriate informed decisions about their antenatal prenatal care.
Review
Methods
Search and Literature Review Strategy
Our search for potentially relevant articles focused on the PsycInfo and PubMed databases. Our search strategy included a combination of keywords and controlled vocabulary terms related to invasive prenatal testing, patient decision-making, and the relevant factors that we were interested in such as socio-demographic characteristics, clinical characteristics, psychological characteristics, knowledge, personal values and beliefs, and attitudes of couples (Figure 1). We used a combination of free-text terms and Medical Subject Headings (MeSH) terms, and we adapted our search strategy to the specific syntax and indexing conventions of each database.
Figure 1. PRISMA diagram of selection process.
PRISMA: Preferred Reporting Items for Systematic reviews and Meta-Analyses
Inclusion and Exclusion Criteria
To ensure the robustness and reliability of our review, we included only articles presenting original, primary research findings which have been vetted through a peer-review process and then published in highly esteemed journals. Methodologically, we expected these articles to use either quantitative or mixed methods, supporting the research with a solid empirical base. The content of the articles had to explore the decision-making process and the factors influencing it regarding invasive prenatal testing among pregnant women or both parents when applicable.
To maintain the specificity and rigor of our review, we did not embed comments, opinions retrospective studies and literature reviews or articles that were not accessible in their full form. Of particular note is that we specifically excluded research focusing exclusively on non-invasive prenatal testing or research generally on prenatal testing, without making clear distinctions between invasive and non-invasive procedures. Finally, we excluded studies focusing in healthcare professional’s attitudes toward invasive prenatal testing.
Study Selection
Duplication of articles was effectively eliminated by utilizing Zotero software, version 6.0.26 (Corporation for Digital Scholarship, Vienna, VA). During the primary phase of this process, two independent reviewers conducted an initial evaluation of the discovered papers' titles and abstracts. In the subsequent phase, these same researchers engaged in an exhaustive examination of the full texts of all remaining studies, aiming to ascertain their eligibility. In addition, we undertook a thorough examination of the reference lists of both included studies and relevant review articles. Any discrepancies between reviewers were resolved by discussion or by a third reviewer if consensus could not be reached.
Data Extraction
All authors participated in data extraction and analysis. The assemblage of data encapsulated insights derived from both the 'results' and 'discussion' sections of the pertinent studies. The authors assiduously collated data across an array of dimensions: the year of publication, the country of the study, participant demographic information, the risk level of the pregnancy, significant factors which influence of decision-making and finally the methodological soundness of the incorporated studies.
For the purposes of data synthesis, a qualitative assimilation of findings was undertaken. This led to the identification of a multitude of factors integral to the decision-making process regarding invasive prenatal testing. These factors spanned various domains such as sociodemographic and clinical characteristics, test characteristics, personal values and beliefs, psychological facets, attitudes towards pregnancy termination, relational aspects, understanding of invasive prenatal testing, and the provision of information (Table 1).
Table 1. Characteristics of included studies .
| Author, Year | Country | Participants (N) | Risk level of pregnancy | Variables | Significant factors for decision-making |
| Lewis et al., 2014 [6] | UK | 1087 women 18 partners | All risk levels | -Sociodemographic characteristics -Psychosocial factors associated with the decision-making process | Time taken to make a decision about invasive tests |
| Grinshpun-Cohen et al., 2015 [7] | Israel | 42 women | High risk | -Sociodemographic characteristics -Knowledge -Attitude toward pregnancy termination -Psychological factors -Decision-making process | -Age as the main reason for undergoing amniocentesis -Less knowledge about the related risk with amniocentesis -Positive correlation between willingness to consider pregnancy termination and amniocentesis uptake -Want certainty, fear of Down's syndrome |
| Grinshpun-Cohen et al., 2015 [13] | Israel | 42 women | Low risk | -Maternal age -Family history | -Impact of advanced maternal age (>35 years old) on the decision for invasive prenatal testing -46,7% amniocentesis of which 86,7% >35 years old |
| Bangsgaard and Tabor, 2013 [14] | Denmark | 543 women 430 partners | All risk levels | -Sociodemographic characteristics -Informed choice -Satisfaction of decision -Fertility treatment | -Most women and men had high degrees of knowledge (82% and 81%) and positive attitudes regarding risk assessment (97% and 98%), leading to 79% and 80% making an informed choice |
| Fumagalli et al., 2018 [15] | Italy | 448 women | Low Risk | -Sociodemographic characteristics -Perceive risk of having a baby with Down's syndrome -Perceive risk of miscarriage of invasive testing | -Impact of perception of risk 1/200 and procedure-related miscarriage on the decision to undergo invasive prenatal testing |
| Dicke et al., 2014 [16] | USA | 2643 women | All risk levels | -Sociodemographic characteristics | -Association between being non-Caucasian and low education level and negative attitude toward invasive prenatal tests |
| Farrell et al., 2014 [17] | USA | 334 women | All risk levels | -Clinical characteristics | -Likelihood of women with a high risk of chromosomal abnormalities undergoing invasive prenatal testing |
| Gil et al., 2015 [18] | UK | 6782 women | All risk levels | -Sociodemographic characteristics -Clinical characteristics | -Association between being non-Caucasian and negative attitude toward invasive prenatal tests -Avoidance of anxiety of waiting results as a reason to refuse invasive investigations following a screening test -Attitude about pregnancy termination: In high-risk or intermediate-risk group women refused invasive testing if they didn’t consider pregnancy termination |
| Chan et al., 2014 [19] | China | 358 women | All risk levels | -Sociodemographic characteristics | -Preference for invasive prenatal diagnosis among those with lower education levels (secondary education or lower) |
| Cheng et al., 2018 [20] | China | 48 women | High risk | -Sociodemographic characteristics -Anxiety and depression -Pregnancy stress | -Anxiety as a predictor of invasive prenatal test uptake |
| Lund et al., 2018 [21] | Denmark | 315 women 102 partners | All risk levels | -Sociodemographic characteristics -Fertility treatment -Knowledge | -Preference for invasive testing among high-risk couples who have undergone fertility treatment |
| Grinshpun-Cohen et al., 2015 [22] | Israel | 49 women | High risk | Attitude toward pregnancy termination -Phycological factors | -The most worried women about pregnancy outcome and the least concerned about amnio-related risks were the most likely to undergo amniocentesis |
| Skutilova, 2015 [23] | Czech Republic | 271 women | All risk levels | -Sociodemographic characteristics -Clinical characteristics - Knowledge and information provision -Decision-making process -Feelings over time about invasive prenatal testing | -Significant correlation between previous spontaneous abortion and negative feelings about amniocentesis -Role of the gynecologist in providing information about invasive prenatal testing -Decision-making process: the main reason for undergoing invasive tests is to make sure the fetus is healthy |
| Farrell et al., 2011 [24] | USA | 139 women | All risk levels | -Sociodemographic characteristics -Knowledge -Decision-making process -Values and beliefs | -Impact of knowledge levels on decisions about chorionic villus sampling, an invasive prenatal test -Values and beliefs about pregnancy termination and raising a child with Down's syndrome |
| Ternby et al., 2015 [25] | Sweden | 161 women | All risk levels | - Sociodemographic characteristics -Reasons accept/decline invasive testing -Kind of information about invasive testing received -Knowledge | -Reasons for accepting: to be sure of the baby’s health -Reasons for decline: termination of pregnancy in case of positive outcome, risk of miscarriage -Most of the women were >35 years old |
| van der Steen et al., 2019 [26] | The Netherlands | 181 women 5 physicians | High risk | Physicians: Level of information, Women: - Sociodemographic characteristics -Impression of physician preference -Information provided -Anxiety | -Influence by physician’s pre-test counseling on the decision to undergo invasive prenatal testing |
| van Schendel et al., 2016 [27] | The Netherlands | 1091 women | High risk | - Sociodemographic characteristics -Attitude toward pregnancy termination -Informed choice -Decisional conflict -Anxiety | -Attitude toward pregnancy termination is higher in women who choose invasive prenatal testing -The majority of women opting for invasive prenatal testing made a decision that aligns with their personal values |
Results
Sociodemographic Characteristics
Sociodemographic characteristics were significant factors across several studies, indicating their strong influence on the decision-making process related to invasive prenatal testing. Specifically, maternal age has been identified as a significant determinant which exhibited a profound effect of advanced maternal age (>35 years) on the choice for invasive prenatal testing. According to the literature among the 46.7% of participants who opted for amniocentesis, a remarkable 86.7% were over 35 years of age [13].
Education levels have been identified as critical variable. An array of studies has indicated a correlation between higher educational attainment and increased utilization of invasive prenatal testing [14,16-18,28,29]. On the other hand, other studies report that invasive testing, as opposed to NIPT, was associated with lower educational background (p=0.023). More specifically, individuals possessing a secondary education or lower were frequently more inclined towards invasive prenatal diagnosis [19,20]. Thus, only 33% of women who exclusively chose invasive prenatal testing had received tertiary education, compared to more than 50% of women in the control group. This inclination is believed to arise due to limited awareness regarding the associated risks of invasive tests.
Ethnicity also carries significant implications. There is evidence showing a propensity among non-Caucasians (Afro-Caribbean) to demonstrate a negative attitude towards both invasive and non-invasive prenatal tests (OR=0.290, p=0.001) [16,18].
Clinical Characteristics
Clinical characteristics also play a pivotal role in the decision to embark on invasive prenatal testing. The women at high risk of chromosomal abnormalities undergoing invasive prenatal testing are substantial [17]. The preference for invasive testing like CVS in 40% of high-risk cases likely reflects its near-absolute diagnostic accuracy, which is crucial for conditions where the risk of chromosomal abnormalities is deemed high based on initial screenings. The number of these cases is underestimated given that women in high or intermediate risk categories often decline invasive testing if they are disinclined to consider the possibility of pregnancy termination. Another study noted that couples categorized as high-risk and who had undergone fertility treatment displayed a preference for invasive testing in comparison with couples who had spontaneous conception, with a statistically significant difference in preferences (0.56 versus 0.10; p<0.05) [21].
Psychological and Emotional Factors
Psychological factors hold substantial weight in the decision-making process regarding invasive prenatal testing. Among them, anxiety is identified as the primary determinant [20]. Another study highlighted the integral role of psychological considerations, determining that women who were most worried about pregnancy outcomes and least concerned about the risks related to amniocentesis were more likely to undergo the procedure [22]. An additional investigation explored how psychosocial variables influence the time women require to make decisions about invasive tests, signifying their relevance in the decision-making timeline [6]. Furthermore, there seems to be a direct correlation between a woman's willingness to consider pregnancy termination, deeply rooted in psychological and moral stances, and the inclination to undergo amniocentesis, which implies that fears, such as the possibility of Down's syndrome, play a critical role in these choices [7].
Level of Knowledge and Provided Information
In the patient decision-making process, the provision and depth of knowledge are of paramount importance. As expected, a comprehensive understanding facilitates more informed decisions [14]. In contrast, the lack of adequate knowledge is a decisive factor in the uptake of procedures [7]. Separate research highlights how previous experiences, such as undergoing fertility treatments, may influence high-risk couples' inclination towards invasive testing [21]. The pivotal role of gynecologists in steering these decisions is also underscored [23], while further investigations highlighted the profound impact of both the quality and nature of information received [24,25]. Moreover, the importance of well-curated information is further emphasized in literature. This way decisions align with individuals' core values, particularly when contemplating potential pregnancy termination [26].
Personal Beliefs and Attitudes Toward Pregnancy Termination
The existing literature highlights the significant influence of attitudes towards pregnancy termination on the uptake of invasive prenatal testing. A positive correlation between the willingness to consider pregnancy termination and the choice of amniocentesis is pinpointed [7]. Similarly, it was observed that women who prioritized the outcomes of their pregnancy, and showed less concern about amniocentesis risks, were more inclined to opt for the procedure [22]. This becomes obvious by the fact that women over 35 years of age irrespective of the risk for Down's syndrome opted for invasive testing (17 out of 30 women). This perspective was further strengthened by data that indicated a stronger preference for invasive prenatal testing among women with heightened termination considerations, with their choices predominantly aligning with their personal values [27]. Additionally, separate research emphasized that individuals in high or intermediate-risk categories showcased a pronounced hesitation towards invasive testing when they wouldn't contemplate termination as a feasible option [18].
Discussion
The aim of this review was to investigate the factors influencing the decision-making process for undergoing invasive prenatal testing.
Our findings underscore the significant role of advanced maternal age (>35 years) in elective invasive prenatal testing [7,13]. The common knowledge that the possibility of chromosomal abnormalities, increases with maternal age, could be a major factor behind such decision. The role of educational attainment in relation to the decision-making process is paramount and has profound implications. Evidence from our review indicates a dichotomy in which women with advanced educational backgrounds and those with secondary education or less are predisposed to opt for invasive diagnostic procedures. The first category is characterized by a better overall understanding of their available options [14,16-19,28,29]. Conversely, the second category may be influenced by partial or misinformed perspectives on the invasive procedure, such as the risk of miscarriage [19,20]. Distinct patterns were also observed between ethnic groups. In particular, non-Caucasian women (Afro-Caribbean) showed a reluctance toward invasive prenatal testing [16,18]. Such ethnic diversity indicates the presence of embedded cultural values and social influences.
The clinical characteristics of certain patient groups significantly highlight their own importance. This is particularly evident in the case of women at high risk for chromosomal abnormalities, as well as couples who have undergone the complex journey of fertility treatments [17,21]. These groups demonstrate a noticeable preference for invasive testing, highlighting the necessity for personalized informational and psychological support tailored to their unique circumstances. It can be hypothesized that couples who have put their trust in science to have a child they are ready to follow scientific indications for prenatal diagnosis even if there is a minor risk of miscarriage associated with diagnostic procedure. Furthermore, there exists a notable dichotomy in the decision-making process of women classified as high or intermediate risk [17,21]. These women often exhibit reluctance, or even outright refusal, to undergo invasive testing, especially in scenarios where pregnancy termination is not considered as an option [13,22]. Anyway, the interest lies within cases that termination of pregnancy is an option, and this should be addressed first to make clear if consultation could alter the couple’s decision. Otherwise, putting the fetus at risk of miscarriage is not justified as it can be examined soon after birth. In general, this observation warrants a more in-depth exploration into the ways risk perceptions and decision-making processes develop in these specific contexts.
Invasive testing risk can be expressed in terms of both numerical relevance and acceptability. Perceived acceptability seems to affect the interpretation of a given risk more than the numerical relevance of the risk [15]. A woman may consider the 1/200 risk of miscarriage non-negligible but acceptable, and she may decide to undergo invasive testing. In comparison, a woman may consider the 1/350 risk of carrying a foetus with Down's syndrome negligible but unacceptable and consequently may decide to undergo invasive testing. These findings suggest that acceptability should be a key focus in counselling communication.
From the psychological and emotional factors, anxiety unfolds as pivotal in the decision-making process, revealing a delicate balance where emotional, psychological, and factual knowledge intricately weave into decisions. In our study, we have demonstrated that women experiencing elevated levels of anxiety are more inclined to choose invasive prenatal diagnostic procedures. This inclination arises from their desire to obtain comprehensive information regarding the health status of the fetus, despite the associated risk of miscarriage [6,7,20,22]. The pivotal role of psychological and emotional factors is not only salient in the acceptance of invasive testing but also perceptibly intertwined with decision-making timelines, possibly indicating a potential gap where additional psychological support may be harbored to aid in timelier, informed decisions. The involvement of midwives in this decision-making process is crucial. Midwives, with their expertise in providing holistic care, can play a vital role in offering emotional support to women, navigating through the complexities of prenatal screening decisions [30]. Their presence can contribute to a more comprehensive understanding of the emotional and psychological factors influencing a woman's choice, thereby fostering a balanced and informed decision-making process [30]. Collaborative efforts between healthcare professionals, including midwives, obstetricians, fetal medicine doctors, neonatologists, geneticists, and phycologists may enhance the overall support system available to women during this critical phase of decision-making.
Knowledge and information dissemination stand out as critical determinants, emphasizing that while the depth of knowledge plays a quintessential role in bolstering informed decisions, the sources, quality, and alignment of information with personal values emerge as equally crucial [7,14,21]. In the realm of prenatal screening decisions, the notable impact of healthcare professionals, particularly obstetricians and fetal medicine specialists, in steering decisions throws into relief the necessity of ensuring that these professionals are armed with not only accurate and up-to-date information but also the skills to communicate these effectively and empathetically [23-25].
The pivotal role of healthcare providers extends beyond the mere provision of information, as their ability to navigate and address the emotional and psychological aspects of decision-making significantly influences patient choices [23]. This underscores the importance of integrating psychological training into the education and professional development of healthcare professionals involved in prenatal care. Furthermore, the establishment of interdisciplinary collaboration, including midwives, can contribute significantly to enhancing the holistic support provided to women during this critical decision-making phase [30]. These collaborative efforts not only broaden the spectrum of emotional support available but also reinforce the collaborative nature of healthcare delivery, promoting a more patient-centered approach.
Attitudes towards termination of pregnancy, as another factor influencing the decision-making process, reveal a nuanced landscape where personal beliefs, religious considerations, legal restrictions, and perspectives on disability converge. Within this complex context, religion emerges as an important determinant, shaping individuals' views on the morality of abortion. For instance, having a strong religious faith, particularly in belief systems like Islam countries that vehemently denounce termination of pregnancy, coupled with residing in countries where abortion is prohibited by law, significantly impacts women's decisions to abstain from any form of prenatal testing [31].
Personal beliefs aside, the legal landscape further complicates the discourse. The existence of legal frameworks that restrict or prohibit termination of pregnancy introduces a level of complexity, potentially affecting not only the availability of abortion services but also the social perception of the procedure [31,32]. Considering the specific legal restrictions and their impact on reproductive rights provides essential context for understanding the broader dynamics surrounding termination of pregnancy. Furthermore, delving into the realm of attitudes towards disability adds another layer of complexity. Attitudes toward life and disability contribute significantly to ethical considerations regarding decisions related to invasive prenatal testing. Individuals or couples may face complex ethical dilemmas when faced with the prospect of potential disabilities in the unborn child, further emphasizing the deeply personal nature of these decisions [33].
Tying these multifaceted elements together, it becomes apparent that the moral and ethical compass guiding decisions about invasive prenatal testing is deeply shaped by a combination of personal beliefs, religious values, legal constraints, and disability perspectives. Recognizing this complex interplay highlights the importance of adopting a counseling and decision support approach that is not only respectful of individual beliefs but also ethically and morally sensitive to the various factors that influence the decision-making process regarding pregnancy termination.
Conclusions
In conclusion, this systematic review provides a comprehensive exploration of the multiple factors influencing the decision-making process for undergoing invasive prenatal testing. The findings have revealed a complex interplay of demographic, clinical, psychological, informational, and attitudinal factors shaping choices individuals and couples make in this critical aspect of reproductive healthcare. In light these findings, it is evident that a holistic and patient-centered approach, involving interdisciplinary collaboration and comprehensive support systems, is essential in navigating the intricate landscape of decision-making surrounding invasive prenatal testing. During this process healthcare professionals should make clear the indications and risks to the couples and finally respect their decisions. That said tailored interventions and policies aiming to promoted informed, balanced, and ethically sensitive choices in prenatal testing should be developed.
The authors have declared financial relationships, which are detailed in the next section.
Panagiota Tzela declare(s) a grant from University of West Attica, Special Account for Research Grants (ELKE).
Author Contributions
Concept and design: Panagiota Tzela, Nikolaos Antonakopoulos, Kleanthi Gourounti
Acquisition, analysis, or interpretation of data: Panagiota Tzela, Dimitrios Kanellopoulos, Panagiotis Antsaklis
Drafting of the manuscript: Panagiota Tzela, Dimitrios Kanellopoulos, Nikolaos Antonakopoulos
Critical review of the manuscript for important intellectual content: Panagiotis Antsaklis, Nikolaos Antonakopoulos, Kleanthi Gourounti
Supervision: Kleanthi Gourounti
References
- 1.Invasive prenatal diagnostic techniques. Wapner RJ. Semin Perinatol. 2005;29:401–404. doi: 10.1053/j.semperi.2006.01.003. [DOI] [PubMed] [Google Scholar]
- 2.Swedish Council on Health Technology Assessment. SBU Assessments No. 246. Stockholm, Sweden: 2016. Prenatal diagnosis through chromosomal microarray analysis (CMA) (summary and conclusions) [PubMed] [Google Scholar]
- 3.Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis. Akolekar R, Beta J, Picciarelli G, Ogilvie C, D'Antonio F. Ultrasound Obstet Gynecol. 2015;45:16–26. doi: 10.1002/uog.14636. [DOI] [PubMed] [Google Scholar]
- 4.Factors affecting the uptake of prenatal screening tests for congenital anomalies; a multicentre prospective cohort study. Gitsels-van der Wal JT, Verhoeven PS, Manniën J, Martin L, Reinders HS, Spelten E, Hutton EK. BMC Pregnancy Childbirth. 2014;14:264. doi: 10.1186/1471-2393-14-264. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.The impact of ethical beliefs on decisions about prenatal screening tests: searching for justification. García E, Timmermans DR, van Leeuwen E. Soc Sci Med. 2008;66:753–764. doi: 10.1016/j.socscimed.2007.10.010. [DOI] [PubMed] [Google Scholar]
- 6.Non-invasive prenatal testing for trisomy 21: a cross-sectional survey of service users' views and likely uptake. Lewis C, Hill M, Silcock C, Daley R, Chitty LS. BJOG. 2014;121:582–594. doi: 10.1111/1471-0528.12579. [DOI] [PubMed] [Google Scholar]
- 7.A priori attitudes predict amniocentesis uptake in women of advanced maternal age: a pilot study. Grinshpun-Cohen J, Miron-Shatz T, Rhee-Morris L, Briscoe B, Pras E, Towner D. J Health Commun. 2015;20:1107–1113. doi: 10.1080/10810730.2015.1018632. [DOI] [PubMed] [Google Scholar]
- 8.Shared decision making: a model for clinical practice. Elwyn G, Frosch D, Thomson R, et al. J Gen Intern Med. 2012;27:1361–1367. doi: 10.1007/s11606-012-2077-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.The multi-dimensional measure of informed choice: a validation study. Michie S, Dormandy E, Marteau TM. Patient Educ Couns. 2002;48:87–91. doi: 10.1016/s0738-3991(02)00089-7. [DOI] [PubMed] [Google Scholar]
- 10.Shared decision making: examining key elements and barriers to adoption into routine clinical practice. Légaré F, Witteman HO. Health Aff (Millwood) 2013;32:276–284. doi: 10.1377/hlthaff.2012.1078. [DOI] [PubMed] [Google Scholar]
- 11.Patient-centered prenatal counseling: aligning obstetric healthcare professionals with needs of pregnant women. Farrell RM, Nutter B, Agatisa PK. Women Health. 2015;55:280–296. doi: 10.1080/03630242.2014.996724. [DOI] [PubMed] [Google Scholar]
- 12.Shared decision making--pinnacle of patient-centered care. Barry MJ, Edgman-Levitan S. N Engl J Med. 2012;366:780–781. doi: 10.1056/NEJMp1109283. [DOI] [PubMed] [Google Scholar]
- 13.The limited effect of information on Israeli pregnant women at advanced maternal age who decide to undergo amniocentesis. Grinshpun-Cohen J, Miron-Shatz T, Berkenstet M, Pras E. Isr J Health Policy Res. 2015;4:23. doi: 10.1186/s13584-015-0019-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Do pregnant women and their partners make an informed choice about first trimester risk assessment for Down syndrome, and are they satisfied with the choice? Bangsgaard L, Tabor A. Prenat Diagn. 2013;33:146–152. doi: 10.1002/pd.4026. [DOI] [PubMed] [Google Scholar]
- 15.Prenatal diagnosis tests and women's risk perception: a cross-sectional study. Fumagalli S, Antolini L, Nespoli A, Vergani P, Ferrazzi E, Oggioni S, Locatelli A. J Psychosom Obstet Gynaecol. 2018;39:73–81. doi: 10.1080/0167482X.2017.1291622. [DOI] [PubMed] [Google Scholar]
- 16.The utilization and choices of aneuploidy screening in a midwestern population. Dicke JM, Van Duyne L, Bradshaw R. J Genet Couns. 2014;23:874–880. doi: 10.1007/s10897-014-9711-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.What women want: lead considerations for current and future applications of noninvasive prenatal testing in prenatal care. Farrell RM, Agatisa PK, Nutter B. Birth. 2014;41:276–282. doi: 10.1111/birt.12113. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.UK NHS pilot study on cell-free DNA testing in screening for fetal trisomies: factors affecting uptake. Gil MM, Giunta G, Macalli EA, Poon LC, Nicolaides KH. Ultrasound Obstet Gynecol. 2015;45:67–73. doi: 10.1002/uog.14683. [DOI] [PubMed] [Google Scholar]
- 19.Patient's choice between a non-invasive prenatal test and invasive prenatal diagnosis based on test accuracy. Chan YM, Leung TY, Chan OK, Cheng YK, Sahota DS. Fetal Diagn Ther. 2014;35:193–198. doi: 10.1159/000356075. [DOI] [PubMed] [Google Scholar]
- 20.Psychological factors influencing choice of prenatal diagnosis in Chinese multiparous women with advanced maternal age. Cheng BH, Chen JH, Wang GH. J Matern Fetal Neonatal Med. 2019;32:2295–2301. doi: 10.1080/14767058.2018.1432038. [DOI] [PubMed] [Google Scholar]
- 21.Preferences for prenatal testing among pregnant women, partners and health professionals. Lund ICB, Becher N, Petersen OB, Hill M, Chitty L, Vogel I. https://content.ugeskriftet.dk/sites/default/files/scientific_article_files/2018-08/a5486.pdf. Dan Med J. 2018;65:1–6. [PubMed] [Google Scholar]
- 22.Factors that affect the decision to undergo amniocentesis in women with normal Down syndrome screening results: it is all about the age. Grinshpun-Cohen J, Miron-Shatz T, Ries-Levavi L, Pras E. Health Expect. 2015;18:2306–2317. doi: 10.1111/hex.12200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Knowledge, attitudes and decision-making in Czech women with atypical results of prenatal screening tests for the most common chromosomal and morphological congenital defects in the fetus: selected questionnaire results. Skutilova V. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015;159:156–162. doi: 10.5507/bp.2013.046. [DOI] [PubMed] [Google Scholar]
- 24.Meeting patients' education and decision-making needs for first trimester prenatal aneuploidy screening. Farrell RM, Nutter B, Agatisa PK. Prenat Diagn. 2011;31:1222–1228. doi: 10.1002/pd.2867. [DOI] [PubMed] [Google Scholar]
- 25.Information and knowledge about Down syndrome among women and partners after first trimester combined testing. Ternby E, Ingvoldstad C, Annerén G, Lindgren P, Axelsson O. Acta Obstet Gynecol Scand. 2015;94:329–332. doi: 10.1111/aogs.12560. [DOI] [PubMed] [Google Scholar]
- 26.Offering a choice between NIPT and invasive PND in prenatal genetic counseling: the impact of clinician characteristics on patients' test uptake. van der Steen SL, Houtman D, Bakkeren IM, et al. Eur J Hum Genet. 2019;27:235–243. doi: 10.1038/s41431-018-0287-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Trial by Dutch laboratories for evaluation of non-invasive prenatal testing. Part II-women's perspectives. van Schendel RV, Page-Christiaens GC, Beulen L, et al. Prenat Diagn. 2016;36:1091–1098. doi: 10.1002/pd.4941. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Women's and healthcare professionals' preferences for prenatal testing: a discrete choice experiment. Beulen L, Grutters JP, Faas BH, Feenstra I, Groenewoud H, van Vugt JM, Bekker MN. Prenat Diagn. 2015;35:549–557. doi: 10.1002/pd.4571. [DOI] [PubMed] [Google Scholar]
- 29.Amniocentesis test uptake for congenital defects: Decision of pregnant women in Vietnam. Canh Chuong N, Minh Duc D, Anh ND, Thi Vui L, Pham Sy Cuong L, Thi Thuy Duong D, Thi Thu Ha B. Health Care Women Int. 2018;39:493–504. doi: 10.1080/07399332.2018.1424168. [DOI] [PubMed] [Google Scholar]
- 30.A midwife's role in prenatal screening. Deacon E. Br J Midwifery. 2002;10:485–488. [Google Scholar]
- 31.Women's knowledge and use of prenatal screening tests. Seven M, Akyüz A, Eroglu K, Daack-Hirsch S, Skirton H. J Clin Nurs. 2017;26:1869–1877. doi: 10.1111/jocn.13494. [DOI] [PubMed] [Google Scholar]
- 32.Medico-legal aspects of abortion: updates of the literature. Shakhatreh HJ, Salih AJ, Aldrou KK, Alazzam FA, Issa MS. https://www.ejmanager.com/mnstemps/10/10-1668281946.pdf?t=1713855926. Med Arch. 2022;76:373–376. doi: 10.5455/medarh.2022.76.373-376. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Attitudes toward prenatal testing and pregnancy termination among a diverse population of parents of children with intellectual disabilities. Kuppermann M, Nakagawa S, Cohen SR, Dominguez-Pareto I, Shaffer BL, Holloway SD. Prenat Diagn. 2011;31:1251–1258. doi: 10.1002/pd.2880. [DOI] [PubMed] [Google Scholar]

